Leonard Braden Michael

Average Profitability
<0.0001%
Insider Buys Quantity
65
Insider Buys Sum
$14.55M
Insider Sells Quantity
51
Insider Sells Sum
$28.82M

Insider Activity of Leonard Braden Michael

According to the SEC Form 4 filings, Leonard Braden Michael, being in a position of

  1. 10 percent owner at Aclaris Therapeutics, Inc.,
    оver the last 12 months, has bought 4854052 shares for $5.59M, and sold 0 shares,
    over all time since 2024-06-11, has bought 4854052 shares for $5.59M, and sold 0 shares.

The largest purchase of all time was on 2024-06-28 and amounted to 1201000 shares of Aclaris Therapeutics, Inc. for $1.35M.

The largest sale of all time was on 2022-12-29 and amounted to 3000000 shares of Retractable Technologies, Inc. for $4.8M.

Biography of Leonard Braden Michael

No biography is available at this moment.

2024-08-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
206,025
0.2901%
$1.24$256,357-4.84%
2024-08-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
167,544
0.2372%
$1.29$216,400-7.81%
2024-07-31PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
100,000
0.1421%
$1.33$132,640-0.48%
2024-07-30PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
173,730
0.2425%
$1.30$226,370+1.3%
2024-07-30PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
85,800
0.3983%
$7.15$613,470+5.87%
2024-07-22PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
17,716
0.0249%
$1.33$23,557-11.28%
2024-07-19PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
6,689
0.0092%
$1.30$8,696-10.23%
2024-07-18PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
130,317
0.1816%
$1.30$169,555-9.16%
2024-07-18PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
80,718
0.3739%
$9.11$735,737-23.52%
2024-07-17PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
135,546
0.5761%
$7.75$1.05M-17.26%
2024-07-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
123,017
0.1779%
$1.15$141,3340%
2024-07-03PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
143,288
0.209%
$1.16$166,0710%
2024-07-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
86,092
0.1239%
$1.14$98,4890%
2024-07-01PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
107,434
0.1538%
$1.14$122,1850%
2024-06-28PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
1.2M
1.6972%
$1.12$1.35M0%
2024-06-27PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
235,000
0.3415%
$1.15$271,3310%
2024-06-18PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
50,000
0.0708%
$1.13$56,505+5.31%
2024-06-17PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
150,000
0.2124%
$1.13$169,500+5.31%
2024-06-14PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
345,000
0.5039%
$1.17$402,201+0.85%
2024-06-13PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
528,621
0.7614%
$1.15$607,757-0.42%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.